Cancer Treatment Centers of America at Midwestern Regional Medical Center and Blue Cross Announce In-Network Agreement
Blue Cross members battling cancer now have expanded access to CTCA
Cancer Treatment Centers of America (CTCA) and Blue Cross and Blue Shield of Illinois (BCBSIL) today announced an agreement that makes CTCA at Midwestern Regional Medical Center (Midwestern) an in-network provider of cancer care for its members. The new agreement provides in-network options for members seeking cancer treatment.
"For 77 years, Blue Cross and Blue Shield of Illinois has provided its members with the most expansive provider network available. This new agreement with CTCA furthers that commitment while keeping the cost of care in check and improving health outcomes," said Mike Deering, Director of Public Affairs at Blue Cross.
"Contracts with private payors are important for CTCA, but they're even more important for health plan members who are dealing with complex and advanced stage cancers," says Scott Jones, President and CEO of Cancer Treatment Centers of America at Midwestern Regional Medical Center. "Agreements, like the one established with Blue Cross and Blue Shield of Illinois make it easier for patients to get the care they need from a hospital focused exclusively on serving cancer patients with physicians they trust. This agreement aligns with our goal of creating partnerships that serve the needs of patients and includes aspects that hold our hospital accountable for performance in meeting those needs. There is incredible demand for our services and this agreement allows us to work with BCBSIL in a collaborative way to serve more of those patients who are seeking our care."
CTCA specializes in treating patients with complex or advanced-stage cancer, combining medical expertise and state-of-the-art technology with nutritional counseling, naturopathic medicine, mind-body therapy and spiritual support. CTCA is widely recognized for its innovation, patient satisfaction, patient loyalty ratings, and quality scores. CTCA is also committed to transparency in reporting treatment results and the BCBSIL in-network contract includes key metrics around performance outcomes, efficiency and drug utilization.
CTCA at Midwestern Regional Medical Center has been recognized for innovative and individualized cancer care and leading technology. The hospital has been designated by the National Quality Measures for Breast Centers Program (NQMBC®) as among the top centers in the country for providing quality breast cancer care. The breast cancer center at CTCA at Midwestern is the only Breast Center of Excellence in Illinois, and one of only 40 nationally, to be deemed a Certified Quality Breast Center of Excellence. As a member of the National Marrow Donor Program (NMDP), the Stem Cell Transplant and Cell Therapy Program at CTCA at Midwestern provides a full spectrum of transplantation services and advanced treatment options for hematologic cancers. CTCA at Midwestern is one of only a few hospitals in the nation to combine recent advances in brain mapping and navigation, along with a new device called the BrainPath®. Known as the 6 Pillar Approach, this innovative surgical technique provides CTCA at Midwestern neurosurgical oncologists with improved access to hard to reach tumors and provides more surgical options for patients.
CTCA at Midwestern made great strides in oncology care by enhancing the treatment options and services provided to patients when it opened a Quality of Life Clinic to help patients in treatment address chronic health concerns that can impact cancer treatment and enhance quality of life. Providing advanced cancer care and supporting patients' quality of life have helped CTCA maintain industry leading patient satisfaction scores. More than 90 percent of patients at Midwestern would refer CTCA to family and friends, compared to the national average of 70 percent, according to Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS).